Adam Olshen, PhD, MA

Title(s)Professor, Epidemiology & Biostatistics
SchoolSchool of Medicine
Address1450 Third Street, #267
San Francisco CA 94158
Phone415-514-9406
vCardDownload vCard

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Perturbations in inflammatory pathways are associated with shortness of breath profiles in oncology patients receiving chemotherapy. Support Care Cancer. 2024 Mar 26; 32(4):250. Shin J, Miaskowski C, Wong ML, Yates P, Olshen AB, Roy R, Dokiparthi V, Cooper B, Paul S, Conley YP, Levine JD, Hammer MJ, Kober K. PMID: 38532105.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Torch-eCpG: a fast and scalable eQTM mapper for thousands of molecular phenotypes with graphical processing units. BMC Bioinformatics. 2024 Feb 14; 25(1):71. Kober KM, Berger L, Roy R, Olshen A. PMID: 38355413; PMCID: PMC10867984.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    3. Single Nucleotide Polymorphism (SNP) and Antibody-based Cell Sorting (SNACS): A tool for demultiplexing single-cell DNA sequencing data. bioRxiv. 2024 Feb 10. Ve K, R R, Cac P, A K, E T, Cc S, Ab O. PMID: 38370638; PMCID: PMC10871358.
      View in: PubMed   Mentions:
    4. Effect of a Home-based Walking Intervention on Cardiopulmonary Fitness and Quality of Life Among Men with Prostate Cancer on Active Surveillance: The Active Surveillance Exercise Randomized Controlled Trial. Eur Urol Oncol. 2023 Oct 29. Van Blarigan EL, Kenfield SA, Olshen A, Panchal N, Encabo K, Tenggara I, Graff RE, Bang AS, Shinohara K, Cooperberg MR, Carroll PR, Jones LW, Winters-Stone K, Luke A, Chan JM. PMID: 37907387.
      View in: PubMed   Mentions: 2     Fields:    
    5. Multiomic Single Cell Sequencing Identifies Stemlike Nature of Mixed Phenotype Acute Leukemia and Provides Novel Risk Stratification. bioRxiv. 2023 May 18. Peretz CAC, Kennedy VE, Walia A, Delley CL, Koh A, Tran E, Clark IC, Hayford CE, D'Amato C, Xue Y, Fontanez KM, Roy R, Logan AC, Perl AE, Abate A, Olshen A, Smith CC. PMID: 37292835; PMCID: PMC10245585.
      View in: PubMed   Mentions:
    6. Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemia. Haematologica. 2023 05 01; 108(5):1272-1283. Pariury H, Fandel J, Bachl S, Ang KK, Markossian S, Wilson CG, Braun BS, Popescu B, Wohlfeil M, Beckman K, Xirenayi S, Roy RP, Olshen AB, Smith C, Arkin MR, Loh ML, Diaz-Flores E. PMID: 36700399; PMCID: PMC10153511.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    7. Prediction of morning fatigue severity in outpatients receiving chemotherapy: less may still be more. Support Care Cancer. 2023 Apr 11; 31(5):253. Kober KM, Roy R, Conley Y, Dhruva A, Hammer MJ, Levine J, Olshen A, Miaskowski C. PMID: 37039882.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Epigenetic Regulation of Inflammatory Mechanisms and a Psychological Symptom Cluster in Patients Receiving Chemotherapy. Nurs Res. 2023 May-Jun 01; 72(3):200-210. Harris CS, Miaskowski CA, Conley YP, Hammer MJ, Dunn LB, Dhruva AA, Levine JD, Olshen AB, Kober KM. PMID: 36929768; PMCID: PMC10121746.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    9. Torch-eCpG: A fast and scalable eQTM mapper for thousands of molecular phenotypes with graphical processing units. bioRxiv. 2023 Mar 10. Kober KM, Berger L, Roy R, Olshen A. PMID: 36945384; PMCID: PMC10028892.
      View in: PubMed   Mentions:
    10. Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts. PLoS One. 2023; 18(3):e0282177. Lee RH, Roy R, Li H, Hechmer A, Zhu TR, Izgutdina A, Olshen AB, Johnson DE, Grandis JR. PMID: 36857322; PMCID: PMC9977000.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    11. Does multi-way, long-range chromatin contact data advance 3D genome reconstruction? BMC Bioinformatics. 2023 Feb 24; 24(1):64. Olshen AB, Segal MR. PMID: 36829114; PMCID: PMC9951495.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    12. Sleep disturbance is associated with perturbations in immune-inflammatory pathways in oncology outpatients undergoing chemotherapy. Sleep Med. 2023 01; 101:305-315. Calvo-Schimmel A, Kober KM, Paul SM, Cooper BA, Harris C, Shin J, Hammer MJ, Conley YP, Dokiparthi V, Olshen A, Levine JD, Miaskowski C. PMID: 36470166.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Perturbations in common and distinct inflammatory pathways associated with morning and evening fatigue in outpatients receiving chemotherapy. Cancer Med. 2023 03; 12(6):7369-7380. Kober KM, Harris C, Conley YP, Dhruva A, Dokiparthi V, Hammer MJ, Levine JD, Oppegaard K, Paul S, Shin J, Sucher A, Wright F, Yuen B, Olshen AB, Miaskowski C. PMID: 36373573; PMCID: PMC10067125.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    14. Perturbations in Neuroinflammatory Pathways Are Associated With a Worst Pain Profile in Oncology Patients Receiving Chemotherapy. J Pain. 2023 01; 24(1):84-97. Shin J, Kober KM, Harris C, Oppegaard K, Calvo-Schimmel A, Paul SM, Cooper BA, Olshen A, Dokiparthi V, Conley YP, Hammer M, Levine JD, Miaskowski C. PMID: 36115520.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    15. Gastrointestinal Symptom Cluster is Associated With Epigenetic Regulation of Lymphotoxin Beta in Oncology Patients Receiving Chemotherapy. Biol Res Nurs. 2023 Jan; 25(1):51-64. Harris CS, Miaskowski CA, Conley YP, Hammer MJ, Dhruva AA, Levine JD, Olshen AB, Kober KM. PMID: 35929442; PMCID: PMC9900252.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    16. Association between Ancestry-Specific 6q25 Variants and Breast Cancer Subtypes in Peruvian Women. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1602-1609. Zavala VA, Casavilca-Zambrano S, Navarro-Vásquez J, Castañeda CA, Valencia G, Morante Z, Calderón M, Abugattas JE, Gómez H, Fuentes HA, Liendo-Picoaga R, Cotrina JM, Monge C, Neciosup SP, Huntsman S, Hu D, Sánchez SE, Williams MA, Núñez-Marrero A, Godoy L, Hechmer A, Olshen AB, Dutil J, Ziv E, Zabaleta J, Gelaye B, Vásquez J, Gálvez-Nino M, Enriquez-Vera D, Vidaurre T, Fejerman L. PMID: 35654312; PMCID: PMC9662925.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    17. COVIDNearTerm: A simple method to forecast COVID-19 hospitalizations. J Clin Transl Sci. 2022; 6(1):e59. Olshen AB, Garcia A, Kapphahn KI, Weng Y, Vargo J, Pugliese JA, Crow D, Wesson PD, Rutherford GW, Gonen M, Desai M. PMID: 35720970; PMCID: PMC9161046.
      View in: PubMed   Mentions: 5  
    18. Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors. J Exp Med. 2022 04 04; 219(4). Jiang H, Muir RK, Gonciarz RL, Olshen AB, Yeh I, Hann BC, Zhao N, Wang YH, Behr SC, Korkola JE, Evans MJ, Collisson EA, Renslo AR. PMID: 35262628; PMCID: PMC8916116.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    19. Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia. Haematologica. 2022 01 01; 107(1):178-186. Hecht A, Meyer JA, Behnert A, Wong E, Chehab F, Olshen A, Hechmer A, Aftandilian C, Bhat R, Choi SW, Chonat S, Farrar JE, Fluchel M, Frangoul H, Han JH, Kolb EA, Kuo DJ, MacMillan ML, Maese L, Maloney KW, Narendran A, Oshrine B, Schultz KR, Sulis ML, Van Mater D, Tasian SK, Hofmann WK, Loh ML, Stieglitz E. PMID: 33375775; PMCID: PMC8719097.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    20. Discovering dominant tumor immune archetypes in a pan-cancer census. Cell. 2022 01 06; 185(1):184-203.e19. Combes AJ, Samad B, Tsui J, Chew NW, Yan P, Reeder GC, Kushnoor D, Shen A, Davidson B, Barczak AJ, Adkisson M, Edwards A, Naser M, Barry KC, Courau T, Hammoudi T, Argüello RJ, Rao AA, Olshen AB, Immunoprofiler Consortium, Cai C, Zhan J, Davis KC, Kelley RK, Chapman JS, Atreya CE, Patel A, Daud AI, Ha P, Diaz AA, Kratz JR, Collisson EA, Fragiadakis GK, Erle DJ, Boissonnas A, Asthana S, Chan V, Krummel MF. PMID: 34963056; PMCID: PMC8862608.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    21. Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer. JCI Insight. 2021 10 22; 6(20). Bouhaddou M, Lee RH, Li H, Bhola NE, O'Keefe RA, Naser M, Zhu TR, Nwachuku K, Duvvuri U, Olshen AB, Roy R, Hechmer A, Bolen J, Keysar SB, Jimeno A, Mills GB, Vandenberg S, Swaney DL, Johnson DE, Krogan NJ, Grandis JR. PMID: 34546978; PMCID: PMC8564908.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    22. Exploring the genetic and epigenetic origins of juvenile myelomonocytic leukemia using newborn screening samples. Leukemia. 2022 01; 36(1):279-282. Behnert A, Meyer J, Parsa JY, Hechmer A, Loh ML, Olshen A, de Smith AJ, Stieglitz E. PMID: 34183765; PMCID: PMC8720242.
      View in: PubMed   Mentions: 4     Fields:    
    23. In utero and early-life exposure to thirdhand smoke causes profound changes to the immune system. Clin Sci (Lond). 2021 04 30; 135(8):1053-1063. Snijders AM, Zhou M, Whitehead TP, Fitch B, Pandey P, Hechmer A, Huang A, Schick SF, de Smith AJ, Olshen AB, Metayer C, Mao JH, Wiemels JL, Wiemels JL, Kogan SC. PMID: 33851706; PMCID: PMC8086195.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsPHPublic Health
    24. The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers. Sci Rep. 2021 04 27; 11(1):9091. Majumder A, Sandhu M, Banerji D, Steri V, Olshen A, Moasser MM. PMID: 33907275; PMCID: PMC8079373.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    25. Prediction of evening fatigue severity in outpatients receiving chemotherapy: less may be more. Fatigue. 2021; 9(1):14-32. Kober KM, Roy R, Dhruva A, Conley YP, Chan RJ, Cooper B, Olshen A, Miaskowski C. PMID: 34249477; PMCID: PMC8262130.
      View in: PubMed   Mentions: 3  
    26. Pan-cancer identification of clinically relevant genomic subtypes using outcome-weighted integrative clustering. Genome Med. 2020 12 03; 12(1):110. Arora A, Olshen AB, Seshan VE, Shen R. PMID: 33272320; PMCID: PMC7716509.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    27. International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia. Clin Cancer Res. 2021 01 01; 27(1):158-168. Schönung M, Meyer J, Nöllke P, Olshen AB, Hartmann M, Murakami N, Wakamatsu M, Okuno Y, Plass C, Loh ML, Niemeyer CM, Muramatsu H, Flotho C, Stieglitz E, Lipka DB. PMID: 33139265; PMCID: PMC7785676.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    28. Human pediatric B-cell acute lymphoblastic leukemias can be classified as B-1 or B-2-like based on a minimal transcriptional signature. Exp Hematol. 2020 10; 90:65-71.e1. Fitch B, Roy R, Geng H, Montecino-Rodriguez E, Bengtsson H, Gaillard C, Hiam K, Casero D, Olshen AB, Dorshkind K, Kogan SC. PMID: 32946981; PMCID: PMC7606616.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    29. Ribosome profiling reveals a functional role for autophagy in mRNA translational control. Commun Biol. 2020 07 17; 3(1):388. Goldsmith J, Marsh T, Asthana S, Leidal AM, Suresh D, Olshen A, Debnath J. PMID: 32681145; PMCID: PMC7367890.
      View in: PubMed   Mentions: 5  Translation:AnimalsCells
    30. Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes. J Clin Invest. 2020 02 03; 130(2):863-876. Meyer LK, Huang BJ, Delgado-Martin C, Roy RP, Hechmer A, Wandler AM, Vincent TL, Fortina P, Olshen AB, Wood BL, Horton TM, Shannon KM, Teachey DT, Hermiston ML. PMID: 31687977; PMCID: PMC6994137.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    31. Differential methylation and expression of genes in the hypoxia-inducible factor 1 signaling pathway are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors and with preclinical models of chemotherapy-induced neuropathic pain. Mol Pain. 2020 Jan-Dec; 16:1744806920936502. Kober KM, Lee MC, Olshen A, Conley YP, Sirota M, Keiser M, Hammer MJ, Abrams G, Schumacher M, Levine JD, Miaskowski C. PMID: 32586194; PMCID: PMC7322824.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    32. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features. Ophthalmology. 2020 06; 127(6):804-813. Afshar AR, Pekmezci M, Bloomer MM, Cadenas NJ, Stevers M, Banerjee A, Roy R, Olshen AB, Van Ziffle J, Onodera C, Devine WP, Grenert JP, Bastian BC, Solomon DA, Damato BE. PMID: 32139107; PMCID: PMC7246167.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    33. Targeted Genomic Profiling of Acral Melanoma. J Natl Cancer Inst. 2019 10 01; 111(10):1068-1077. Yeh I, Jorgenson E, Shen L, Xu M, North JP, Shain AH, Reuss D, Wu H, Robinson WA, Olshen A, von Deimling A, Kwok PY, Bastian BC, Asgari MM. PMID: 30657954; PMCID: PMC6792090.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    34. Next-Generation Sequencing of Uveal Melanoma for Detection of Genetic Alterations Predicting Metastasis. Transl Vis Sci Technol. 2019 Mar; 8(2):18. Afshar AR, Damato BE, Stewart JM, Zablotska LB, Roy R, Olshen AB, Joseph NM, Bastian BC. PMID: 31024753; PMCID: PMC6472431.
      View in: PubMed   Mentions: 18     Fields:    
    35. Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantation. Clin Transplant. 2019 03; 33(3):e13487. Harel E, Shoji J, Abraham V, Miller L, Laszik Z, Thurison T, King A, Olshen A, Leung J, Szabo G, Hann B, Høyer-Hansen G, Craik CS, Vincenti F. PMID: 30689221.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    36. A Pilot Study Using a Multistaged Integrated Analysis of Gene Expression and Methylation to Evaluate Mechanisms for Evening Fatigue in Women Who Received Chemotherapy for Breast Cancer. Biol Res Nurs. 2019 03; 21(2):142-156. Flowers E, Flentje A, Levine J, Olshen A, Hammer M, Paul S, Conley Y, Miaskowski C, Kober KM. PMID: 30701989; PMCID: PMC6700896.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    37. Magnetic resonance spectroscopy (MRS) can identify painful lumbar discs and may facilitate improved clinical outcomes of lumbar surgeries for discogenic pain. Eur Spine J. 2019 04; 28(4):674-687. Gornet MG, Peacock J, Claude J, Schranck FW, Copay AG, Eastlack RK, Benz R, Olshen A, Lotz JC. PMID: 30610465.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    38. Expression of mitochondrial dysfunction-related genes and pathways in paclitaxel-induced peripheral neuropathy in breast cancer survivors. Mol Pain. 2018 Jan-Dec; 14:1744806918816462. Kober KM, Olshen A, Conley YP, Schumacher M, Topp K, Smoot B, Mazor M, Chesney M, Hammer M, Paul SM, Levine JD, Miaskowski C. PMID: 30426838; PMCID: PMC6293373.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    39. Phenotypic Characterization of Paclitaxel-Induced Peripheral Neuropathy in Cancer Survivors. J Pain Symptom Manage. 2018 12; 56(6):908-919.e3. Kober KM, Mazor M, Abrams G, Olshen A, Conley YP, Hammer M, Schumacher M, Chesney M, Smoot B, Mastick J, Paul SM, Levine JD, Miaskowski C. PMID: 30172061; PMCID: PMC6289693.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    40. ABVD Without Radiation for Newly Diagnosed Pediatric and Young Adult Patients With Hodgkin Lymphoma: A Single Center Retrospective Analysis of 28 Consecutive Patients. J Pediatr Hematol Oncol. 2018 05; 40(4):290-294. Stieglitz E, Dinh T, Phelps AS, Pampaloni MH, Olshen AB, Robbins E. PMID: 29432308.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    41. Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. Pediatr Blood Cancer. 2018 07; 65(7):e27034. Dvorak CC, Satwani P, Stieglitz E, Cairo MS, Dang H, Pei Q, Gao Y, Wall D, Mazor T, Olshen AB, Parker JS, Kahwash S, Hirsch B, Raimondi S, Patel N, Skeens M, Cooper T, Mehta PA, Grupp SA, Loh ML. PMID: 29528181; PMCID: PMC5980696.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    42. Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL. J Med Imaging (Bellingham). 2018 01; 5(1):011014. Olshen A, Wolf D, Jones EF, Newitt D, van ‘t Veer LJ, Yau C, Esserman L, Wulfkuhle JD, Gallagher RI, Singer L, Petricoin EF, Hylton N, Park CC. PMID: 29296631; PMCID: PMC5741993.
      View in: PubMed   Mentions: 3  
    43. Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia. Nat Commun. 2017 12 19; 8(1):2127. Stieglitz E, Mazor T, Olshen AB, Geng H, Gelston LC, Akutagawa J, Lipka DB, Plass C, Flotho C, Chehab FF, Braun BS, Costello JF, Loh ML. PMID: 29259179; PMCID: PMC5736624.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCellsCTClinical Trials
    44. Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1. Proc Natl Acad Sci U S A. 2017 10 03; 114(40):10743-10748. Mazor T, Chesnelong C, Pankov A, Jalbert LE, Hong C, Hayes J, Smirnov IV, Marshall R, Souza CF, Shen Y, Viswanath P, Noushmehr H, Ronen SM, Jones SJM, Marra MA, Cairncross JG, Perry A, Nelson SJ, Chang SM, Bollen AW, Molinaro AM, Bengtsson H, Olshen AB, Weiss S, Phillips JJ, Luchman HA, Costello JF. PMID: 28916733; PMCID: PMC5635900.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCells
    45. Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis. Blood. 2017 07 06; 130(1):48-58. Smith CC, Paguirigan A, Jeschke GR, Lin KC, Massi E, Tarver T, Chin CS, Asthana S, Olshen A, Travers KJ, Wang S, Levis MJ, Perl AE, Radich JP, Shah NP. PMID: 28490572; PMCID: PMC5501146.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCTClinical Trials
    46. Establishment and characterization of an oral tongue squamous cell carcinoma cell line from a never-smoking patient. Oral Oncol. 2017 06; 69:1-10. Wang SJ, Asthana S, van Zante A, Heaton CM, Phuchareon J, Stein L, Higuchi S, Kishimoto T, Chiu CY, Olshen AB, McCormick F, Tetsu O. PMID: 28559012; PMCID: PMC5479323.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    47. Quantitative proteomic analyses of mammary organoids reveals distinct signatures after exposure to environmental chemicals. Proc Natl Acad Sci U S A. 2016 Mar 08; 113(10):E1343-51. Williams KE, Lemieux GA, Hassis ME, Olshen AB, Fisher SJ, Werb Z. PMID: 26903627; PMCID: PMC4790982.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimals
    48. Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia. Nat Genet. 2016 Jan; 48(1):101. Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, Esquivel E, Yu A, Seepo S, Olsen SR, Rosenberg M, Archambeault SL, Abusin G, Beckman K, Brown PA, Briones M, Carcamo B, Cooper T, Dahl GV, Emanuel PD, Fluchel MN, Goyal RK, Hayashi RJ, Hitzler J, Hugge C, Liu YL, Messinger YH, Mahoney DH, Monteleone P, Nemecek ER, Roehrs PA, Schore RJ, Stine KC, Takemoto CM, Toretsky JA, Costello JF, Olshen AB, Stewart C, Li Y, Ma J, Gerbing RB, Alonzo TA, Getz G, Gruber TA, Golub TR, Stegmaier K, Loh ML. PMID: 26711114.
      View in: PubMed   Mentions: 1     Fields:    
    49. Development and Validation of a Gene-Based Model for Outcome Prediction in Germ Cell Tumors Using a Combined Genomic and Expression Profiling Approach. PLoS One. 2015; 10(12):e0142846. Korkola JE, Heck S, Olshen AB, Feldman DR, Reuter VE, Houldsworth J, Bosl GJ, Chaganti RS. PMID: 26624623; PMCID: PMC4666461.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    50. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat Biotechnol. 2016 Feb; 34(2):155-63. Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, Gao J, Socci ND, Solit DB, Olshen AB, Schultz N, Taylor BS. PMID: 26619011; PMCID: PMC4744099.
      View in: PubMed   Mentions: 399     Fields:    Translation:Humans
    51. The genomic landscape of juvenile myelomonocytic leukemia. Nat Genet. 2015 Nov; 47(11):1326-1333. Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, Esquivel E, Yu A, Seepo S, Olsen S, Rosenberg M, Archambeault SL, Abusin G, Beckman K, Brown PA, Briones M, Carcamo B, Cooper T, Dahl GV, Emanuel PD, Fluchel MN, Goyal RK, Hayashi RJ, Hitzler J, Hugge C, Liu YL, Messinger YH, Mahoney DH, Monteleone P, Nemecek ER, Roehrs PA, Schore RJ, Stine KC, Takemoto CM, Toretsky JA, Costello JF, Olshen AB, Stewart C, Li Y, Ma J, Gerbing RB, Alonzo TA, Getz G, Gruber T, Golub T, Stegmaier K, Loh ML. PMID: 26457647; PMCID: PMC4626387.
      View in: PubMed   Mentions: 117     Fields:    Translation:HumansCells
    52. DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors. Cancer Cell. 2015 Sep 14; 28(3):307-317. Mazor T, Pankov A, Johnson BE, Hong C, Hamilton EG, Bell RJA, Smirnov IV, Reis GF, Phillips JJ, Barnes MJ, Idbaih A, Alentorn A, Kloezeman JJ, Lamfers MLM, Bollen AW, Taylor BS, Molinaro AM, Olshen AB, Chang SM, Song JS, Costello JF. PMID: 26373278; PMCID: PMC4573399.
      View in: PubMed   Mentions: 133     Fields:    Translation:HumansCells
    53. Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Nat Genet. 2015 Oct; 47(10):1194-9. Shain AH, Garrido M, Botton T, Talevich E, Yeh I, Sanborn JZ, Chung J, Wang NJ, Kakavand H, Mann GJ, Thompson JF, Wiesner T, Roy R, Olshen AB, Gagnon A, Gray JW, Huh N, Hur JS, Busam KJ, Scolyer RA, Cho RJ, Murali R, Bastian BC. PMID: 26343386; PMCID: PMC4589486.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansCells
    54. DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly. Genome Res. 2014 Dec; 24(12):2022-32. Scheinin I, Sie D, Bengtsson H, van de Wiel MA, Olshen AB, van Thuijl HF, van Essen HF, Eijk PP, Rustenburg F, Meijer GA, Reijneveld JC, Wesseling P, Pinkel D, Albertson DG, Ylstra B. PMID: 25236618; PMCID: PMC4248318.
      View in: PubMed   Mentions: 180     Fields:    Translation:HumansCells
    55. Dynamics of chronic myeloid leukemia response to dasatinib, nilotinib, and high-dose imatinib. Haematologica. 2014 Nov; 99(11):1701-9. Olshen A, Tang M, Cortes J, Gonen M, Hughes T, Branford S, Quintás-Cardama A, Michor F. PMID: 25216683; PMCID: PMC4222479.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    56. Changes in abundance of oral microbiota associated with oral cancer. PLoS One. 2014; 9(6):e98741. Schmidt BL, Kuczynski J, Bhattacharya A, Huey B, Corby PM, Queiroz EL, Nightingale K, Kerr AR, DeLacure MD, Veeramachaneni R, Olshen AB, Albertson DG, Muy-Teck Teh. PMID: 24887397; PMCID: PMC4041887.
      View in: PubMed   Mentions: 172     Fields:    Translation:Humans
    57. Recurrent epimutations activate gene body promoters in primary glioblastoma. Genome Res. 2014 May; 24(5):761-74. Nagarajan RP, Zhang B, Bell RJ, Johnson BE, Olshen AB, Sundaram V, Li D, Graham AE, Diaz A, Fouse SD, Smirnov I, Song J, Paris PL, Wang T, Costello JF. PMID: 24709822; PMCID: PMC4009606.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    58. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science. 2014 Jan 10; 343(6167):189-193. Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K, Asthana S, Jalbert LE, Nelson SJ, Bollen AW, Gustafson WC, Charron E, Weiss WA, Smirnov IV, Song JS, Olshen AB, Cha S, Zhao Y, Moore RA, Mungall AJ, Jones SJM, Hirst M, Marra MA, Saito N, Aburatani H, Mukasa A, Berger MS, Chang SM, Taylor BS, Costello JF. PMID: 24336570; PMCID: PMC3998672.
      View in: PubMed   Mentions: 700     Fields:    Translation:Humans
    59. The translational landscape of the mammalian cell cycle. Mol Cell. 2013 Nov 21; 52(4):574-82. Stumpf CR, Moreno MV, Olshen AB, Taylor BS, Ruggero D. PMID: 24120665; PMCID: PMC3959127.
      View in: PubMed   Mentions: 118     Fields:    Translation:HumansAnimalsCells
    60. Assessing gene-level translational control from ribosome profiling. Bioinformatics. 2013 Dec 01; 29(23):2995-3002. Olshen AB, Hsieh AC, Stumpf CR, Olshen RA, Ruggero D, Taylor BS. PMID: 24048356; PMCID: PMC3834798.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansAnimalsCells
    61. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat Med. 2013 May; 19(5):619-25. Sadanandam A, Lyssiotis CA, Homicsko K, Collisson EA, Gibb WJ, Wullschleger S, Ostos LC, Lannon WA, Grotzinger C, Del Rio M, Lhermitte B, Olshen AB, Wiedenmann B, Cantley LC, Gray JW, Hanahan D. PMID: 23584089; PMCID: PMC3774607.
      View in: PubMed   Mentions: 501     Fields:    Translation:HumansCells
    62. Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein. J Pathol. 2013 Apr; 229(5):743-754. Kobos R, Nagai M, Tsuda M, Merl MY, Saito T, Laé M, Mo Q, Olshen A, Lianoglou S, Leslie C, Ostrovnaya I, Antczak C, Djaballah H, Ladanyi M. PMID: 23288701; PMCID: PMC4083568.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    63. Pattern discovery and cancer gene identification in integrated cancer genomic data. Proc Natl Acad Sci U S A. 2013 Mar 12; 110(11):4245-50. Mo Q, Wang S, Seshan VE, Olshen AB, Schultz N, Sander C, Powers RS, Ladanyi M, Shen R. PMID: 23431203; PMCID: PMC3600490.
      View in: PubMed   Mentions: 186     Fields:    Translation:Humans
    64. β1-Integrin via NF-κB signaling is essential for acquisition of invasiveness in a model of radiation treated in situ breast cancer. Breast Cancer Res. 2013; 15(4):R60. Nam JM, Ahmed KM, Costes S, Zhang H, Onodera Y, Olshen AB, Hatanaka KC, Kinoshita R, Ishikawa M, Sabe H, Shirato H, Park CC. PMID: 23883667; PMCID: PMC3978561.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    65. Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients. Cancer Res. 2013 Jan 01; 73(1):30-40. Magbanua MJ, Sosa EV, Roy R, Eisenbud LE, Scott JH, Olshen A, Pinkel D, Rugo HS, Park JW. PMID: 23135909; PMCID: PMC4085329.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    66. Integrative subtype discovery in glioblastoma using iCluster. PLoS One. 2012; 7(4):e35236. Shen R, Mo Q, Schultz N, Seshan VE, Olshen AB, Huse J, Ladanyi M, Sander C. PMID: 22539962; PMCID: PMC3335101.
      View in: PubMed   Mentions: 102     Fields:    Translation:HumansCells
    67. Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis. Clin Cancer Res. 2011 Nov 15; 17(22):7024-34. Bhattacharya A, Roy R, Snijders AM, Hamilton G, Paquette J, Tokuyasu T, Bengtsson H, Jordan RC, Olshen AB, Pinkel D, Schmidt BL, Albertson DG. PMID: 22068658; PMCID: PMC3226754.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    68. The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma. Cell. 2011 Oct 28; 147(3):554-64. Oricchio E, Nanjangud G, Wolfe AL, Schatz JH, Mavrakis KJ, Jiang M, Liu X, Bruno J, Heguy A, Olshen AB, Socci ND, Teruya-Feldstein J, Weis-Garcia F, Tam W, Shaknovich R, Melnick A, Himanen JP, Chaganti RS, Wendel HG. PMID: 22036564; PMCID: PMC3208379.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansAnimalsCells
    69. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer. 2012 Feb; 51(2):127-39. Wang L, Motoi T, Khanin R, Olshen A, Mertens F, Bridge J, Dal Cin P, Antonescu CR, Singer S, Hameed M, Bovee JV, Hogendoorn PC, Socci N, Ladanyi M. PMID: 22034177; PMCID: PMC3235801.
      View in: PubMed   Mentions: 106     Fields:    Translation:HumansCells
    70. Parent-specific copy number in paired tumor-normal studies using circular binary segmentation. Bioinformatics. 2011 Aug 01; 27(15):2038-46. Olshen AB, Bengtsson H, Neuvial P, Spellman PT, Olshen RA, Seshan VE. PMID: 21666266; PMCID: PMC3137217.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    71. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet. 2011 Jun 05; 43(7):668-72. Bott M, Brevet M, Taylor BS, Shimizu S, Ito T, Wang L, Creaney J, Lake RA, Zakowski MF, Reva B, Sander C, Delsite R, Powell S, Zhou Q, Shen R, Olshen A, Rusch V, Ladanyi M. PMID: 21642991; PMCID: PMC4643098.
      View in: PubMed   Mentions: 314     Fields:    Translation:HumansCells
    72. Clonality: an R package for testing clonal relatedness of two tumors from the same patient based on their genomic profiles. Bioinformatics. 2011 Jun 15; 27(12):1698-9. Ostrovnaya I, Seshan VE, Olshen AB, Begg CB. PMID: 21546399; PMCID: PMC3106202.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    73. Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy. J Thorac Oncol. 2011 May; 6(5):864-74. Brevet M, Shimizu S, Bott MJ, Shukla N, Zhou Q, Olshen AB, Rusch V, Ladanyi M. PMID: 21774103.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    74. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med. 2011 Apr; 17(4):500-3. Collisson EA, Sadanandam A, Olson P, Gibb WJ, Truitt M, Gu S, Cooc J, Weinkle J, Kim GE, Jakkula L, Feiler HS, Ko AH, Olshen AB, Danenberg KL, Tempero MA, Spellman PT, Hanahan D, Gray JW. PMID: 21460848; PMCID: PMC3755490.
      View in: PubMed   Mentions: 766     Fields:    Translation:HumansAnimalsCells
    75. Topographic enhancement mapping of the cancer-associated breast stroma using breast MRI. Integr Biol (Camb). 2011 Apr; 3(4):490-6. Nabavizadeh N, Klifa C, Newitt D, Lu Y, Chen YY, Hsu H, Fisher C, Tokayasu T, Olshen AB, Spellman P, Gray JW, Hylton N, Park CC. PMID: 21416100; PMCID: PMC3698966.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    76. Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities. J Oncol. 2011; 2011:798592. Affer M, Dao S, Liu C, Olshen AB, Mo Q, Viale A, Lambek CL, Marr TG, Clarkson BD. PMID: 21436996; PMCID: PMC3062978.
      View in: PubMed   Mentions: 21  
    77. Antitumor activity of SNX-2112, a synthetic heat shock protein-90 inhibitor, in MET-amplified tumor cells with or without resistance to selective MET Inhibition. Clin Cancer Res. 2011 Jan 01; 17(1):122-33. Bachleitner-Hofmann T, Sun MY, Chen CT, Liska D, Zeng Z, Viale A, Olshen AB, Mittlboeck M, Christensen JG, Rosen N, Solit DB, Weiser MR. PMID: 21208906; PMCID: PMC3263825.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    78. Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients. Cancer Res. 2011 Jan 15; 71(2):550-60. Moltzahn F, Olshen AB, Baehner L, Peek A, Fong L, Stöppler H, Simko J, Hilton JF, Carroll P, Blelloch R. PMID: 21098088; PMCID: PMC3022112.
      View in: PubMed   Mentions: 142     Fields:    Translation:Humans
    79. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol. 2010 Oct; 28(10):1097-105. Harris RA, Wang T, Coarfa C, Nagarajan RP, Hong C, Downey SL, Johnson BE, Fouse SD, Delaney A, Zhao Y, Olshen A, Ballinger T, Zhou X, Forsberg KJ, Gu J, Echipare L, O'Geen H, Lister R, Pelizzola M, Xi Y, Epstein CB, Bernstein BE, Hawkins RD, Ren B, Chung WY, Gu H, Bock C, Gnirke A, Zhang MQ, Haussler D, Ecker JR, Li W, Farnham PJ, Waterland RA, Meissner A, Marra MA, Hirst M, Milosavljevic A, Costello JF. PMID: 20852635; PMCID: PMC2955169.
      View in: PubMed   Mentions: 343     Fields:    Translation:HumansCells
    80. Copy number and gene expression differences between African American and Caucasian American prostate cancer. J Transl Med. 2010 Jul 22; 8:70. Rose AE, Satagopan JM, Oddoux C, Zhou Q, Xu R, Olshen AB, Yu JZ, Dash A, Jean-Gilles J, Reuter V, Gerald WL, Lee P, Osman I. PMID: 20649978; PMCID: PMC2913940.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    81. A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data. Stat Med. 2010 Jul 10; 29(15):1608-21. Ostrovnaya I, Olshen AB, Seshan VE, Orlow I, Albertson DG, Begg CB. PMID: 20205270; PMCID: PMC3145177.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    82. A classification model for distinguishing copy number variants from cancer-related alterations. BMC Bioinformatics. 2010 Jun 02; 11:297. Ostrovnaya I, Nanjangud G, Olshen AB. PMID: 20525196; PMCID: PMC2897829.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    83. Genetic analysis of the early natural history of epithelial ovarian carcinoma. PLoS One. 2010 Apr 26; 5(4):e10358. Pothuri B, Leitao MM, Levine DA, Viale A, Olshen AB, Arroyo C, Bogomolniy F, Olvera N, Lin O, Soslow RA, Robson ME, Offit K, Barakat RR, Boyd J. PMID: 20436685; PMCID: PMC2859950.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    84. Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors. J Clin Oncol. 2009 Nov 01; 27(31):5240-7. Korkola JE, Houldsworth J, Feldman DR, Olshen AB, Qin LX, Patil S, Reuter VE, Bosl GJ, Chaganti RS. PMID: 19770384; PMCID: PMC3651602.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    85. Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis. Bioinformatics. 2009 Nov 15; 25(22):2906-12. Shen R, Olshen AB, Ladanyi M. PMID: 19759197; PMCID: PMC2800366.
      View in: PubMed   Mentions: 341     Fields:    Translation:Humans
    86. The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene. J Pathol. 2009 Jan; 217(1):83-93. Filion C, Motoi T, Olshen AB, Laé M, Emnett RJ, Gutmann DH, Perry A, Ladanyi M, Labelle Y. PMID: 18855877; PMCID: PMC4429309.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    87. Pathway activation in large B-cell non-Hodgkin lymphoma cell lines by doxorubicin reveals prognostic markers of in vivo response. Leuk Lymphoma. 2008 Nov; 49(11):2170-80. Houldsworth J, Petlakh M, Olshen AB, Chaganti RS. PMID: 19021061.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    88. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci U S A. 2008 Mar 18; 105(11):4340-5. Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J, Friedman E, Narod S, Olshen AB, Gregersen P, Kosarin K, Olsh A, Bergeron J, Ellis NA, Klein RJ, Clark AG, Norton L, Dean M, Boyd J, Offit K. PMID: 18326623; PMCID: PMC2393811.
      View in: PubMed   Mentions: 169     Fields:    Translation:HumansCells
    89. Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping. BMC Genet. 2008 Feb 05; 9:14. Olshen AB, Gold B, Lohmueller KE, Struewing JP, Satagopan J, Stefanov SA, Eskin E, Kirchhoff T, Lautenberger JA, Klein RJ, Friedman E, Norton L, Ellis NA, Viale A, Lee CS, Borgen PI, Clark AG, Offit K, Boyd J. PMID: 18251999; PMCID: PMC2259380.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    90. CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy. Blood. 2008 Apr 01; 111(7):3403-6. Zhou P, Comenzo RL, Olshen AB, Bonvini E, Koenig S, Maslak PG, Fleisher M, Hoffman J, Jhanwar S, Young JW, Nimer SD, Boruchov AM. PMID: 18216299; PMCID: PMC2275009.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    91. In vivo differentiation and genomic evolution in adult male germ cell tumors. Genes Chromosomes Cancer. 2008 Jan; 47(1):43-55. Korkola JE, Heck S, Olshen AB, Reuter VE, Bosl GJ, Houldsworth J, Chaganti RS. PMID: 17943972.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    92. Associations among multiple markers and complex disease: models, algorithms, and applications. Adv Genet. 2008; 60:437-64. Assimes TL, Olshen AB, Narasimhan B, Olshen RA. PMID: 18358329.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    93. Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL-) amyloidosis is associated with response to high-dose melphalan. Blood. 2008 Jan 15; 111(2):549-57. Zhou P, Teruya-Feldstein J, Lu P, Fleisher M, Olshen A, Comenzo RL. PMID: 17982021; PMCID: PMC2200859.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    94. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas. J Pathol. 2007 Jun; 212(2):143-51. Laé M, Ahn EH, Mercado GE, Chuai S, Edgar M, Pawel BR, Olshen A, Barr FG, Ladanyi M. PMID: 17471488.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    95. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics. 2007 Mar 15; 23(6):657-63. Venkatraman ES, Olshen AB. PMID: 17234643.
      View in: PubMed   Mentions: 491     Fields:    
    96. Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells. Stem Cells. 2007 Mar; 25(3):771-8. Chadalavada RS, Korkola JE, Houldsworth J, Olshen AB, Bosl GJ, Studer L, Chaganti RS. PMID: 17138961.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    97. Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer. 2006 Apr 18; 6:96. Fridlyand J, Snijders AM, Ylstra B, Li H, Olshen A, Segraves R, Dairkee S, Tokuyasu T, Ljung BM, Jain AN, McLennan J, Ziegler J, Chin K, Devries S, Feiler H, Gray JW, Waldman F, Pinkel D, Albertson DG. PMID: 16620391; PMCID: PMC1459181.
      View in: PubMed   Mentions: 114     Fields:    Translation:HumansCells
    98. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Res. 2006 Mar 15; 66(6):2970-9. López-Ríos F, Chuai S, Flores R, Shimizu S, Ohno T, Wakahara K, Illei PB, Hussain S, Krug L, Zakowski MF, Rusch V, Olshen AB, Ladanyi M. PMID: 16540645.
      View in: PubMed   Mentions: 95     Fields:    Translation:Humans
    99. p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas. Int J Gynecol Cancer. 2006 Mar-Apr; 16(2):849-53. Anderson SE, Nonaka D, Chuai S, Olshen AB, Chi D, Sabbatini P, Soslow RA. PMID: 16681772.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    100. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res. 2006 Jan 15; 66(2):820-7. Korkola JE, Houldsworth J, Chadalavada RS, Olshen AB, Dobrzynski D, Reuter VE, Bosl GJ, Chaganti RS. PMID: 16424014.
      View in: PubMed   Mentions: 131     Fields:    Translation:HumansCells
    101. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest. 2006 Jan; 116(1):271-84. Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, Fleisher M, Lilja H, Brogi E, Boyd J, Sanchez-Carbayo M, Holland EC, Cordon-Cardo C, Scher HI, Tempst P. PMID: 16395409; PMCID: PMC1323259.
      View in: PubMed   Mentions: 203     Fields:    Translation:HumansCells
    102. Molecular profiling of endometrial cancers from African-American and Caucasian women. Gynecol Oncol. 2006 May; 101(2):209-13. Ferguson SE, Olshen AB, Levine DA, Viale A, Barakat RR, Boyd J. PMID: 16380157.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    103. Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas. Blood. 2006 Mar 15; 107(6):2477-85. Chen W, Houldsworth J, Olshen AB, Nanjangud G, Chaganti S, Venkatraman ES, Halaas J, Teruya-Feldstein J, Zelenetz AD, Chaganti RS. PMID: 16317097; PMCID: PMC1895737.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    104. Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma. Gynecol Oncol. 2006 Apr; 101(1):86-91. Leiser AL, Anderson SE, Nonaka D, Chuai S, Olshen AB, Chi DS, Soslow RA. PMID: 16289259.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    105. Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice. Genome Biol. 2005; 6(10):R84. Huang S, Li Y, Chen Y, Podsypanina K, Chamorro M, Olshen AB, Desai KV, Tann A, Petersen D, Green JE, Varmus HE. PMID: 16207355; PMCID: PMC1257467.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsCells
    106. Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL. Blood. 2005 Nov 15; 106(10):3383-5. Moskowitz CH, Zelenetz AD, Kewalramani T, Hamlin P, Lessac-Chenen S, Houldsworth J, Olshen A, Chaganti R, Nimer S, Teruya-Feldstein J. PMID: 16091454.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    107. Genes that mediate breast cancer metastasis to lung. Nature. 2005 Jul 28; 436(7050):518-24. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massagué J. PMID: 16049480; PMCID: PMC1283098.
      View in: PubMed   Mentions: 1436     Fields:    Translation:HumansCells
    108. Gene expression-based classification of nonseminomatous male germ cell tumors. Oncogene. 2005 Jul 28; 24(32):5101-7. Korkola JE, Houldsworth J, Dobrzynski D, Olshen AB, Reuter VE, Bosl GJ, Chaganti RS. PMID: 15870693.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    109. Stratification of intermediate-risk endometrial cancer patients into groups at high risk or low risk for recurrence based on tumor gene expression profiles. Clin Cancer Res. 2005 Mar 15; 11(6):2252-7. Ferguson SE, Olshen AB, Viale A, Barakat RR, Boyd J. PMID: 15788674.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    110. Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent human embryonal carcinoma cells. Funct Integr Genomics. 2005 Apr; 5(2):59-69. Chadalavada RS, Houldsworth J, Olshen AB, Bosl GJ, Studer L, Chaganti RS. PMID: 15690164.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    111. Identifying site-specific metastasis genes and functions. Cold Spring Harb Symp Quant Biol. 2005; 70:149-58. Gupta GP, Minn AJ, Kang Y, Siegel PM, Serganova I, Cordón-Cardo C, Olshen AB, Gerald WL, Massagué J. PMID: 16869748.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimalsCells
    112. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics. 2004 Oct; 5(4):557-72. Olshen AB, Venkatraman ES, Lucito R, Wigler M. PMID: 15475419.
      View in: PubMed   Mentions: 1043     Fields:    Translation:HumansCells
    113. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer. 2004 Sep 15; 101(6):1455-62. Leitao MM, Soslow RA, Nonaka D, Olshen AB, Aghajanian C, Sabbatini P, Dupont J, Hensley M, Sonoda Y, Barakat RR, Anderson S. PMID: 15316901.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    114. Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma. Ann Oncol. 2004 Aug; 15(8):1261-6. Yoon SS, Segal NH, Olshen AB, Brennan MF, Singer S. PMID: 15277268.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    115. Collaboration of homologous recombination and nonhomologous end-joining factors for the survival and integrity of mice and cells. Genes Dev. 2004 Jun 01; 18(11):1293-304. Couëdel C, Mills KD, Barchi M, Shen L, Olshen A, Johnson RD, Nussenzweig A, Essers J, Kanaar R, Li GC, Alt FW, Jasin M. PMID: 15175261; PMCID: PMC420355.
      View in: PubMed   Mentions: 69     Fields:    Translation:AnimalsCells
    116. Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma. Gynecol Oncol. 2004 Feb; 92(2):719-25. Ferguson SE, Olshen AB, Viale A, Awtrey CS, Barakat RR, Boyd J. PMID: 14766275.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    117. Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas. Blood. 2004 Mar 01; 103(5):1862-8. Houldsworth J, Olshen AB, Cattoretti G, Donnelly GB, Teruya-Feldstein J, Qin J, Palanisamy N, Shen Y, Dyomina K, Petlakh M, Pan Q, Zelenetz AD, Dalla-Favera R, Chaganti RS. PMID: 14615382.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    118. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol. 2003 Nov; 163(5):1765-70. Bastian BC, Olshen AB, LeBoit PE, Pinkel D. PMID: 14578177; PMCID: PMC1892437.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansCells
    119. BARD1 participates with BRCA1 in homology-directed repair of chromosome breaks. Mol Cell Biol. 2003 Nov; 23(21):7926-36. Westermark UK, Reyngold M, Olshen AB, Baer R, Jasin M, Moynahan ME. PMID: 14560035; PMCID: PMC207645.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansAnimalsCells
    120. Angiogenesis impairment in Id-deficient mice cooperates with an Hsp90 inhibitor to completely suppress HER2/neu-dependent breast tumors. Proc Natl Acad Sci U S A. 2003 Oct 14; 100(21):12337-42. de Candia P, Solit DB, Giri D, Brogi E, Siegel PM, Olshen AB, Muller WJ, Rosen N, Benezra R. PMID: 14526102; PMCID: PMC218759.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    121. Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Res. 2003 Oct; 13(10):2291-305. Lucito R, Healy J, Alexander J, Reiner A, Esposito D, Chi M, Rodgers L, Brady A, Sebat J, Troge J, West JA, Rostan S, Nguyen KC, Powers S, Ye KQ, Olshen A, Venkatraman E, Norton L, Wigler M. PMID: 12975311; PMCID: PMC403708.
      View in: PubMed   Mentions: 129     Fields:    Translation:HumansCells
    122. Insights into extramedullary tumour cell growth revealed by expression profiling of human plasmacytomas and multiple myeloma. Br J Haematol. 2003 Sep; 122(5):728-44. Hedvat CV, Comenzo RL, Teruya-Feldstein J, Olshen AB, Ely SA, Osman K, Zhang Y, Kalakonda N, Nimer SD. PMID: 12930383.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    123. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res. 2003 Jun 01; 63(11):2872-80. Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, Carroll P, Kuo WL, Pinkel D, Albertson D, Cordon-Cardo C, Jain AN, Waldman FM. PMID: 12782593.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    124. Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol. Cancer Res. 2003 May 01; 63(9):2139-44. Solit DB, Basso AD, Olshen AB, Scher HI, Rosen N. PMID: 12727831.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansAnimalsCells
    125. Quantitation of apoptotic activity following castration in human prostatic tissue in vivo. Prostate. 2003 Feb 15; 54(3):212-9. Staack A, Kassis AP, Olshen A, Wang Y, Wu D, Carroll PR, Grossfeld GD, Cunha GR, Hayward SW. PMID: 12518326.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    126. Deriving quantitative conclusions from microarray expression data. Bioinformatics. 2002 Jul; 18(7):961-70. Olshen AB, Jain AN. PMID: 12117794.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    127. Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. Cancer Res. 2002 Jul 01; 62(13):3636-40. Massion PP, Kuo WL, Stokoe D, Olshen AB, Treseler PA, Chin K, Chen C, Polikoff D, Jain AN, Pinkel D, Albertson DG, Jablons DM, Gray JW. PMID: 12097266.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCells
    128. Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. Cancer Res. 2002 Feb 15; 62(4):957-60. Wilhelm M, Veltman JA, Olshen AB, Jain AN, Moore DH, Presti JC, Kovacs G, Waldman FM. PMID: 11861363.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    129. A high-resolution radiation hybrid map of the human genome draft sequence. Science. 2001 Feb 16; 291(5507):1298-302. Olivier M, Aggarwal A, Allen J, Almendras AA, Bajorek ES, Beasley EM, Brady SD, Bushard JM, Bustos VI, Chu A, Chung TR, De Witte A, Denys ME, Dominguez R, Fang NY, Foster BD, Freudenberg RW, Hadley D, Hamilton LR, Jeffrey TJ, Kelly L, Lazzeroni L, Levy MR, Lewis SC, Liu X, Lopez FJ, Louie B, Marquis JP, Martinez RA, Matsuura MK, Misherghi NS, Norton JA, Olshen A, Perkins SM, Perou AJ, Piercy C, Piercy M, Qin F, Reif T, Sheppard K, Shokoohi V, Smick GA, Sun WL, Stewart EA, Fernando J, Tran NM, Trejo T, Vo NT, Yan SC, Zierten DL, Zhao S, Sachidanandam R, Trask BJ, Myers RM, Cox DR. PMID: 11181994.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    130. 2-[C-11]thymidine imaging of malignant brain tumors. Cancer Res. 1999 Feb 01; 59(3):615-21. Eary JF, Mankoff DA, Spence AM, Berger MS, Olshen A, Link JM, O'Sullivan F, Krohn KA. PMID: 9973209.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    131. Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy. AJR Am J Roentgenol. 1998 Oct; 171(4):1103-10. Eubank WB, Mankoff DA, Schmiedl UP, Winter TC, Fisher ER, Olshen AB, Graham MM, Eary JF. PMID: 9763005.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    132. Pedigree analysis package vs. MIXD: fitting the mixed model on a large pedigree. Genet Epidemiol. 1996; 13(1):91-106. Olshen AB, Wijsman EM. PMID: 8647381.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    133. Monte Carlo analysis on a large pedigree. Genet Epidemiol. 1993; 10(6):677-82. Thompson EA, Lin S, Olshen AB, Wijsman EM. PMID: 8314080.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Adam's Networks
    Concepts (643)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (159)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.